Article

Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 Program

2026-07-28

Abstract excerpt

<h4>Background: </h4> /Objectives: Since 2021, indeterminate thyroid nodules have been routinely assessed using molecular testing through Quebec’s provincial ThyroSeq v3 pilot project. The primary objective of our study was to compare the molecular and clinicopathological characteristics of Bethesda III and Bethesda IV thyroid nodules evaluated through the pilot project. The secondary objective was to assess the p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f163d992-3f46-50f2-adeb-2c8b38309eca
DOI: 10.20944/preprints202607.2014.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinicopathological, Molecular, and Economic Outcomes of Bethesda III and IV Thyroid Nodules Following Implementation of a Publicly Funded ThyroSeq v3 ProgramDOI 10.20944/preprints202607.2014.v1Read

Molecular Profiling for Bethesda III to VI Nodules: Results of a Multicenter International Retrospective Study.Semantic proximity Read

The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Health Care Setting.Semantic proximity Read

ThyroSeq®V2.0 Molecular Testing: A Cost-Effective Approach for the Evaluation of Indeterminate Thyroid Nodules.Semantic proximity Read

Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.Semantic proximity Read

ThyroSeq overview on indeterminate thyroid nodules: An institutional experience.Semantic proximity Read

Preoperative molecular testing in thyroid nodules with Bethesda VI cytology: Clinical experience and review of the literature.Semantic proximity Read

The utility of ThyroSeq® in the management of indeterminate thyroid nodules by fine-needle aspiration.Semantic proximity Read

Current State of Molecular Cytology in Thyroid Nodules: Platforms and their Diagnostic and Theranostic UtilitySemantic proximity Read

Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules.Semantic proximity Read

Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.Semantic proximity Read

High-risk and intermediate-high-risk results from the ThyroSeq v2 and v3 thyroid genomic classifier are associated with neoplasia: Independent performance assessment at an academic institution.Semantic proximity Read

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read